目的 分析探讨中西医综合治疗原发性中晚期肝癌的临床疗效，制定合理的治疗方法。方法 回顾性收集2013年6 月-2015年6月收治我科原发性肝癌患者103例，均为无手术适应症者。将其为分为观察组和对照组，其中观察组57 例，给予中西医治疗相结合：在西医治疗基础上，进行中医分型辨证施治；对照组46例，给予西医药治疗。两组连 续治疗3个月后比较其临床疗效，对两组患者进行随访1年，观察其生存质量。结果 观察组患者血清ALT含量明显低 于对照组，治疗效果明显高于对照组(P<0.05)，对两组患者进行随访3个月、6个月、12个月发现，观察组经过治疗 后生存质量明显高于对照组(P<0.05)。结论 中西医结合综合治疗中晚期肝癌患者效果好，预后良好，值得临床上 推广使用。

Objective To analyze the clinical curative effect of traditional Chinese herbal medical and western medical integratedly treatment for terminal-stage primary liver cancer, formulate reasonable treatment. Methods Retrospectively collected in June 2013-June 2015, I division of 103 patients with primary liver cancer, who are no surgical indications. They are divided into two groups: observation group and control group, 57 cases of observation group, treatment: the combination of Chinese herbal medicine and western medical treatment, based on the classification of traditional Chinese medicine syndrome differentiation. The control group, 46 cases given western medical treatment. After 3 months compare the clinical curative effect, the two groups patients were followed-up for 3months, 6months, 12months, then compare their survival quality. Results Compared with control group, the level of ALT /AST in serum is lower in the observation group, the treatment effect is significantly higher in the observation group (P<0.05), the two group patients were followed-up for 3 months, 6 months and 12 months, we found that after treatment, the survival quality of observation group is obviously higher than that of control group (P<0.05). Conclusion Combination of Chinese herbal medicine and western medical treatment for terminal-stage primary liver cancer, cause good affect, and can enhance the patients’ survival quality, is worth popularizing clinically used.